Literature DB >> 29332250

The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.

Jelena Juri Mandić1, Ana Kozmar2, Sanja Kusačić-Kuna3, Anamarija Jazbec4, Krešimir Mandić5, Danijela Mrazovac5, Nenad Vukojević5.   

Abstract

PURPOSE: Simultaneous analyses of the contents and ratios of 12 cytokines and growth factors in single samples of human tears were performed, and the results were compared between a group of healthy subjects and a group of patients with Graves' hyperthyreosis (GH) without thyroid-associated orbitopathy (TAO).
METHODS: Determinations and concentration measurements of interleukins (IL-2, IL4, IL-6, IL-8, IL-10, IL-1α, and IL-1β) interferon (IFN-γ), tumor necrosis factor (TNF-α), monocyte chemoattractant protein (MCP-1), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF) were performed with single tear samples from 21 patients with hyperthyreosis and 22 healthy subjects. The analyses were performed using a Randox microchip with an Evidence Biochip Array Analyzer.
RESULTS: We found significant differences between the healthy donor group and the hyperthyreosis group in the levels of IL-6, IL-10, VEGF, IL-1α, and MCP-1. The concentration of IL-6 was considerably higher in the hyperthyreosis group, IL-10 was higher in the healthy donor group, and VEGF and MPC-1 were higher in the hyperthyreosis group. The IL-8 and IFN-γ levels were higher in the hyperthyreosis group. The ratios of all of the cytokines to anti-inflammatory IL-10 were significantly elevated in the hyperthyreosis group.
CONCLUSION: There are clear differences in the levels of cytokines and growth factors in the tears of healthy subjects and patients with GH without TAO. Tear cytokine changes and related dysfunctional tear syndrome (DTS) could be an early sign of occult TAO in Graves' hyperthyreosis patients.

Entities:  

Keywords:  Dysfunctional tear syndrome; Hyperthyroidism; Ocular surface inflammation; Tear cytokines; Thyroid-associated orbitopathy

Mesh:

Substances:

Year:  2018        PMID: 29332250     DOI: 10.1007/s00417-017-3892-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  32 in total

Review 1.  Effect of inflammation on lacrimal gland function.

Authors:  Driss Zoukhri
Journal:  Exp Eye Res       Date:  2005-11-23       Impact factor: 3.467

2.  Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease.

Authors:  T C Chang; K M Huang; T J Chang; S L Lin
Journal:  Clin Endocrinol (Oxf)       Date:  1990-05       Impact factor: 3.478

3.  Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.

Authors:  M Salvi; G Girasole; M Pedrazzoni; M Passeri; N Giuliani; R Minelli; L E Braverman; E Roti
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

Review 4.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

5.  Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome.

Authors:  X Tan; S Sun; Y Liu; T Zhu; K Wang; T Ren; Z Wu; H Xu; L Zhu
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775

6.  Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics.

Authors:  E B Cook; J L Stahl; L Lowe; R Chen; E Morgan; J Wilson; R Varro; A Chan; F M Graziano; N P Barney
Journal:  J Immunol Methods       Date:  2001-08-01       Impact factor: 2.303

7.  Analysis of tear proteins in Graves' ophthalmopathy by high performance liquid chromatography.

Authors:  H A Khalil; R J de Keizer; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1988-08-15       Impact factor: 5.258

Review 8.  [Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface. New concepts for understanding dry eye disease].

Authors:  E Knop; N Knop; H Brewitt
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

9.  Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy.

Authors:  Jin Sook Yoon; Soo Hyun Choi; Joon H Lee; Sung Jun Lee; Sang Yeul Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-21       Impact factor: 3.117

10.  [A new approach for better comprehension of diseases of the ocular surface].

Authors:  C Baudouin
Journal:  J Fr Ophtalmol       Date:  2007-03       Impact factor: 0.818

View more
  6 in total

1.  Autologous Platelet-Rich Plasma Drops for Evaporative Dry Eye Disease from Meibomian Gland Dysfunction: A Pilot Study.

Authors:  Fahmeeda Murtaza; Dana Toameh; Hannah H Chiu; Eric S Tam; Sohel Somani
Journal:  Clin Ophthalmol       Date:  2022-07-06

Review 2.  Ocular surface disease in thyroid eye disease: A narrative review.

Authors:  Harkaran S Rana; Sruti S Akella; Carson E Clabeaux; Zachary P Skurski; Vinay K Aakalu
Journal:  Ocul Surf       Date:  2022-02-12       Impact factor: 6.268

3.  The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.

Authors:  Monika Katko; Erika Galgoczi; Annamaria Erdei; Annamaria Gazdag; Eszter Berta; Miklos Bodor; Ildiko Seres; Ildiko Hircsu; Arpad Badics; Bernadett Ujhelyi; Livia Sira; Harjit Pal Bhattoa; Endre V Nagy
Journal:  J Inflamm Res       Date:  2021-05-12

Review 4.  Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus.

Authors:  Federico Bernabei; Matilde Roda; Marina Buzzi; Marco Pellegrini; Giuseppe Giannaccare; Piera Versura
Journal:  J Clin Med       Date:  2019-09-17       Impact factor: 4.241

Review 5.  Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets.

Authors:  Deanna H Dang; Kamran M Riaz; Dimitrios Karamichos
Journal:  Drugs       Date:  2022-01-13       Impact factor: 9.546

6.  Mechanisms of immune-related differentially expressed genes in thyroid-associated ophthalmopathy based on the GEO database.

Authors:  Yina Gao; Wansen Li
Journal:  Ann Transl Med       Date:  2022-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.